Maryland Heights, MO, February 03, 2017 --(PR.com
)-- The global contraceptive drugs and devices market to reach nearly USD 15.3 Billion in 2020, at a CAGR of 3.5% from 2016 to 2020, due to unmet need and favorable provisions under the affordable care act.
Browse Contraceptive Drugs and Devices Market by Drug Type (Oral Pills, Injectable Drugs and Topical Drugs), and Device Type (Diaphragms - Cervical Cap or Shield, Female Condoms, Intrauterine Devices, Male Condoms, Non-Surgical Permanent Devices, Sponges, Sub-Dermal Implants, and Vaginal Rings) 2016-2020 at https://www.ihealthcareanalyst.com/report/contraceptives-drugs-devices-market/.
The effective contraceptive methods of birth control include intrauterine and implantable birth control devices followed by a number of hormone based methods including oral pills, patches, vaginal rings, and injections. These devices also prevent spreading of sexually transmitted infection. Some of the products such as male condoms and female condoms also help in preventing sexually transmitted infections. Other methods include physical barriers such as condoms, diaphragms and birth control sponges. Different types of contraceptive drugs and devices or birth control methods have large differences in effectiveness, actions required of users, and side effects.
The global contraceptive drugs and devices market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the drug type (oral pills, injectable drugs and topical drugs), device type (diaphragms - cervical cap or shield, female condoms, intrauterine devices, male condoms, non-surgical permanent devices, sponges, sub-dermal implants, and vaginal rings), and forecasts growth trends (CAGR% - 2016 to 2020). The global contraceptive drugs and devices market research report is further segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global contraceptive drugs and devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global contraceptive drugs and devices market and included in this report are Actavis, Inc., Bayer AG, Church & Dwight, Co., Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Pfizer, Inc., Reckitt Benckiser PLC, Teva Pharmaceutical Industries Ltd. and The Female Health Company.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/contraceptives-drugs-devices-market/.
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043